EKF Diagnostics (LON:EKF) Shares Break Above 200 Day Moving Average – What’s Next?

EKF Diagnostics Holdings plc (LON:EKF)’s share price passed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of GBX 25.49 and traded as high as GBX 25.90. EKF Diagnostics shares last traded at GBX 25.90, with a volume of 308,816 shares.

EKF Diagnostics Stock Performance

The company has a current ratio of 4.72, a quick ratio of 1.77 and a debt-to-equity ratio of 2.09. The company has a market cap of £104.47 million, a P/E ratio of 51.91 and a beta of 0.50. The business’s 50 day simple moving average is GBX 25.45 and its 200 day simple moving average is GBX 25.49.

EKF Diagnostics (LON:EKF) last posted its quarterly earnings results on Tuesday, September 15th. The company reported GBX 0.54 earnings per share for the quarter. EKF Diagnostics had a net margin of 4.86% and a return on equity of 3.58%. Sell-side analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current fiscal year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.